Literature DB >> 12764239

Malaria in Austria 1990-2000.

R Strauss1, C Pfeifer.   

Abstract

In Austria, between 1990 and 2000, 924 travel related malaria cases were reported (mean = 84/year). No significant decreasing or increasing trends were observed. P. falciparum (n=517; 55.9%) accounted for the highest number of cases followed by P. vivax or ovale (n=321; 34.7%) and P. malariae (n=29; 2.2%). Most infections were contracted in highly endemic malaria regions (n=686; 74.2%) and most cases were reported from the largest counties: Vienna (n=336, 36.4%), Styria (n=156, 16.8%), and Lower Austria (n=151, 16.3%). Overall, 12 deaths occurred, most were caused by P. falciparum (n=9, 75%; case fatality rate: 1.9%). Data on chemoprophylaxis was available for 752 cases (81.4%) but only half of them (n=367, 48.8%) gave detailed information on the drug used. Data on compliance were obtained for only 45.4% of the cases, with only about 60% of patients completing the full course of prophylaxis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12764239     DOI: 10.2807/esm.08.04.00408-en

Source DB:  PubMed          Journal:  Euro Surveill        ISSN: 1025-496X


  2 in total

1.  Epidemiology and clinical features of imported malaria: a 14-year retrospective single-centre descriptive study in Prague, Czech Republic.

Authors:  Milan Trojánek; Vyacheslav Grebenyuk; Lenka Richterová; Ivana Zicklerová; Eva Nohýnková; Zdenka Manďáková; Jakub Kantor; Hana Roháčová; František Stejskal
Journal:  Malar J       Date:  2022-09-06       Impact factor: 3.469

2.  Epidemiology and clinical features of vivax malaria imported to Europe: sentinel surveillance data from TropNetEurop.

Authors:  N Mühlberger; T Jelinek; J Gascon; M Probst; T Zoller; M Schunk; J Beran; I Gjørup; R H Behrens; J Clerinx; A Björkman; P McWhinney; A Matteelli; R Lopez-Velez; Z Bisoffi; U Hellgren; S Puente; M L Schmid; B Myrvang; M L Holthoff-Stich; H Laferl; C Hatz; H Kollaritsch; A Kapaun; J Knobloch; J Iversen; A Kotlowski; D J M Malvy; P Kern; G Fry; H Siikamaki; M H Schulze; G Soula; M Paul; J Gómez i Prat; V Lehmann; O Bouchaud; S da Cunha; J Atouguia; G Boecken
Journal:  Malar J       Date:  2004-03-08       Impact factor: 2.979

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.